John Derse is joined by M&A experts from across Marsh McLennan to discuss how healthcare organizations can approach antitrust, risk and integration to ensure success and maximize deals. Dr. Subbu Ramanarayanan from NERA shares his insights into the changing antitrust environment. Henry Yuan from Marsh provides his perspectives on mitigating risks across the deal cycle, and Carly McCoy from Mercer explains why the integration phase of deals may be the most critical for